Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs

Background. The use of the bone-seeking properties of bisphosphonates (BPs) to target the delivery of therapeutic drugs is a promising approach for the treatment of bone metastases. Currently, the most advanced example of this approach is a gemcitabine-ibandronate conjugate (GEM-IB), where the bone-...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jost Klawitter, Mckay Easton, Alexander Karpeisky, Kristen B. Farrell, Douglas H. Thamm, Touraj Shokati, Uwe Christians, Shawn Patrick Zinnen
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2025-01-01
Series:	Molecules
Assuntos:	bisphosphonates bone cancer pharmacokinetics gemcitabine ibandronate high-performance liquid chromatography mass spectrometry
Acceso en liña:	https://www.mdpi.com/1420-3049/30/2/354
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!